GnRH Analogues in Cancer and Human Reproduction

1 Reversible inhibition of sexual maturation in male rats: a safety evaluation for the use of LHRH analogues in precocious puberty.- 2 Mechanism of action of GnRH analogues in sexual maturation and function.- 3 Should all girls with central precocious puberty be treated by LHRH analogue?.- 4 Long-term experience with a superactive GnRH analogue in the treatment of precocious puberty.- 5 Effects of GnRH analogues on growth and bone maturation: a role for growth factors and adrenal androgens.- 6 Growth patterns and skeletal maturation during sex steroid suppression and reactivation in central precocious puberty.- 7 Precocious puberty: pathophysiology and treatment.- 8 Effects of GnRH agonists on pituitary gonadotropins: dissociated secretion of subunits in children with precocious puberty treated with [D-Trp6]LHRH microcapsules.- 9 Testicular changes in patients treated with buserelin for precocious puberty.- 10 Influence of buserelin on testicular tissue after long-term treatment for precocious puberty and prostatic cancer.- 11 GnRH analogues in the development of a male contraceptive: importance of testosterone substitution and reversibility of pituitary and testicular suppression.- 12 Clinical pharmacology of LHRH antagonists.- 13 Clinical studies with the Nal-Glu GnRH antagonist.- 14 The clinical relevance of bone mass measurements.- 15 Bone calcium dynamics in women with declining estrogen levels.- 16 Effects of GnRH agonist-induced ovarian suppression on calcium homeostasis and bone metabolism in premenopausal women.- 17 GnRH analogs and safety.- 18 Management of post-marketing surveillance following short-and long-term use of GnRH analogues.